333 filings
Page 4 of 17
8-K
r54 24dj28geenypuv7
9 Dec 21
Regulation FD Disclosure
6:31am
S-3ASR
ekm 9xzvf
19 Nov 21
Automatic shelf registration
5:04pm
8-K
y67spf9 3b
3 Nov 21
Aurinia Reports Third Quarter and Nine Months 2021 Financial Results and Company Updates
12:00am
8-K/A
sjx40oem2
17 Sep 21
Submission of Matters to a Vote of Security Holders
4:03pm
8-K
0j8me2ue
17 Aug 21
Riptide Aurinia Collaboration & License Agreement
4:07pm
8-K
cweu4be
5 Aug 21
Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights
4:12pm
8-K
mxm89wu5odrnbx9guhg
5 Aug 21
Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights
4:11pm
8-K
5j6y2z
19 Jul 21
Aurinia Pharmaceuticals Announces Delisting from the Toronto Stock Exchange
12:00am
S-8
gdgkd6ii
25 Jun 21
Registration of securities for employees
4:31pm
8-K
kunzj4qth7rrq3
25 Jun 21
Regulation FD Disclosure
4:12pm
8-K
9pbxa13p5fyb0cu ox8p
17 Jun 21
Aurinia Announces Addition of Dr. Brinda Balakrishnan to the Board of Directors
4:36pm
8-K
i2gqf593ir0i
10 Jun 21
Departure of Directors or Certain Officers
4:08pm
DEF 14A
odmvkmirhpe ob4sk3
10 May 21
Definitive proxy
4:06pm
10-Q
v5m dxaol84k44a
6 May 21
Quarterly report
4:14pm
8-K
ee3iojnylk42j035vn
6 May 21
Aurinia Reports First Quarter 2021 Financial Results and Recent Operational Highlights
4:08pm
10-K/A
hu1e 0r3c57
30 Apr 21
Annual report (amended)
4:16pm
PRE 14A
8x5qd2zsq402nhx
27 Apr 21
Preliminary proxy
4:32pm
8-K
xh6k3xqqa238p
27 Apr 21
Amendments to Articles of Incorporation or Bylaws
4:17pm